期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CARDIOVASCULAR DRUGS AND THERAPY LetPub Score 7.5
50 ratings
Rate
Reputation 8.8 Influence 6.1 Speed 9.1 | ||||||||||||||||||||||||
期刊簡稱 | CARDIOVASC DRUG THER | ||||||||||||||||||||||||
ISSN | 0920-3206 | ||||||||||||||||||||||||
E-ISSN | 1573-7241 | ||||||||||||||||||||||||
h-index | 63 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 3.20%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.springer.com/10557 | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/cdty/ | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Springer US | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||
創刊年 | 1987 | ||||||||||||||||||||||||
每年文章數 | 101每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 26.52% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0920-3206%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 4.5 Month(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 67.5% | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 下一頁 末頁 (頁 | |
[CARDIOVASCULAR DRUGS AND THERAPY] 的評論 | 撰寫評論 |
作者: 活人玟玉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-23 18:51:37 評論於 How long has editorinvited been invited?(0) 讚! | 活人玟玉 |
作者: 南川傲南 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-21 19:45:19 評論於 Is the external audit fast?(0) 讚! | 南川傲南 |
作者: 南川傲南 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-21 14:12:39 評論於 May I ask, how fast is the review process?(0) 讚! | 南川傲南 |
作者: 邻家困顿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-17 12:50:06 評論於 This is an article in a scientific journal.(0) 讚! | 邻家困顿 |
作者: 巴蜀亦竹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-12 13:09:41 評論於 Currently in the process of investing(0) 讚! | 巴蜀亦竹 |
作者: 四风寄容 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-08 19:12:58 評論於 Does anyone know if this routine article is a regular experimental article?(0) 讚! | 四风寄容 |
作者: Simon Kent 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-17 20:38:48 評論於 Could you please translate the following paragraph into English and Japanese?(0) 讚! | Simon Kent |
作者: 螳螂光泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-09 19:16:28 評論於 Boss, have you won the lottery? How long does this manuscript review take?(0) 讚! | 螳螂光泽 |
作者: 北国半蕾 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-23 23:05:59 評論於 Is this magazine available only online?(0) 讚! | 北国半蕾 |
作者: 北国半蕾 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-23 13:12:47 評論於 Excuse me, how much is the magazine advertising fee?(0) 讚! | 北国半蕾 |
作者: 風見奕诺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-19 23:02:08 評論於 How is it going? It's been 2 weeks since I revised it, and I'm anxiously waiting(0) 讚! | 風見奕诺 |
作者: 風見奕诺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-19 11:37:20 評論於 How did it go later?(0) 讚! | 風見奕诺 |
作者: 风神慧青 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-28 16:14:29 評論於 How long does it usually take to receive the internet? I haven't heard anything yet, and I'm getting anxious(0) 讚! | 风神慧青 |
作者: 苍风思聪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-02 11:56:48 評論於 It's a mistake. It should be 1.5m(0) 讚! | 苍风思聪 |
作者: 苍风思聪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-01 21:49:49 評論於 Research focus: Cardiovascular experience sharing: Submitted a paper for the first review, 1.5 hours for major revision, one reviewer gave minor revisions with acceptance, and another provided good suggestions for improvement. After revising for 2.5 weeks, only one reviewer had a small question, but the editor-in-chief got angry and pointed out poor English, requiring another major revision. Considering the journal under springnature, I decided to use their editing service (PS: shinewrite had previously edited the paper twice). After revising, it was rejected 2 days later. The editor-in-chief said poor writing. Feeling upset, not sure what to say(0) 讚! | 苍风思聪 |
作者: 北冥碧琳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-09-27 08:25:32 評論於 Under review for a week, hoping for good luck, waiting for this article to graduate next year(0) 讚! | 北冥碧琳 |
作者: Mamie Tours 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-09-15 22:23:38 評論於 Today a new article was submitted, with a 20% acceptance rate for the middle draft. I hope the magazine will review it soon(0) 讚! | Mamie Tours |
作者: 蓉沼迁迁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-02 09:47:21 評論於 Couldn't hold steady, fell below 4(0) 讚! | 蓉沼迁迁 |
作者: 金顶书柔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-12-28 18:11:51 評論於 Do I need to scan and upload an ethics review or informed consent form for this magazine?(0) 讚! | 金顶书柔 |
作者: 金顶书柔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-12-28 10:04:42 評論於 Do we need to upload the ethics review or informed consent form for this magazine?(0) 讚! | 金顶书柔 |
作者: LetPub163 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2020-12-13 17:37:21 評論於 The review speed is very fast, and the reviewers gave some friendly opinions. After underwent a major revision and a minor revision, it finally got accepted. There was no page fee, and it is recommended to submit. (3) 讚! | LetPub163 |
作者: 疯魔壬戌 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-12-09 11:26:09 評論於 Review speed: 1.0 | Submission success rate: 75.0 Emphasis on research direction: Clinical drug metabolism Experience sharing: Submitted on October 20, 2020, accepted on December 10, minor revisions. After resubmission, accepted within 3 working days, reviewers are very professional, providing constructive and friendly suggestions that help improve the content of the article. They are the type of reviewers that will help you find relevant references. Language requirements may be strict, so it is recommended to polish the article before resubmitting(0) 讚! | 疯魔壬戌 |
作者: 应龙梦泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-12-04 11:33:48 評論於 Can you share the review cycle, please? Thank you very much(0) 讚! | 应龙梦泽 |
作者: 应龙梦泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-12-04 08:18:57 評論於 Can you share the review period, thank you(0) 讚! | 应龙梦泽 |
作者: 是你的亚鑫呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-09-19 17:21:45 評論於 Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: The magazine feels very fast in reviewing, the comments given are pertinent, and many people around me have been accepted. We must maintain a stable Impact Factor!(0) 讚! | 是你的亚鑫呀 |
首頁 上一頁 1 2 3 下一頁 末頁 (頁 |
Contact us